187 related articles for article (PubMed ID: 10188722)
1. Genetic pattern of prostate cancer progression.
Saric T; Brkanac Z; Troyer DA; Padalecki SS; Sarosdy M; Williams K; Abadesco L; Leach RJ; O'Connell P
Int J Cancer; 1999 Apr; 81(2):219-24. PubMed ID: 10188722
[TBL] [Abstract][Full Text] [Related]
2. Loss of heterozygosity at 7q31.1 and 12p13-12 in advanced prostate cancer.
Kawana Y; Ichikawa T; Suzuki H; Ueda T; Komiya A; Ichikawa Y; Furuya Y; Akakura K; Igarashi T; Ito H
Prostate; 2002 Sep; 53(1):60-4. PubMed ID: 12210480
[TBL] [Abstract][Full Text] [Related]
3. Loss of heterozygosity and microsatellite instability at chromosomal sites 1Q and 10Q in morphologically distinct regions of late stage prostate lesions.
Latini JM; Rieger-Christ KM; Wang DS; Silverman ML; Libertino JA; Summerhayes IC
J Urol; 2001 Nov; 166(5):1931-6. PubMed ID: 11586263
[TBL] [Abstract][Full Text] [Related]
4. Loss of heterozygosity during the development and progression of differentiated adenocarcinoma of the stomach.
Nishizuka S; Tamura G; Terashima M; Satodate R
J Pathol; 1998 May; 185(1):38-43. PubMed ID: 9713358
[TBL] [Abstract][Full Text] [Related]
5. Genetic heterogeneity of surgically resected prostate carcinomas and their biopsy specimens is related to their histologic differentiation.
Takimoto Y; Shimazui T; Akaza H; Sato N; Noguchi M
Cancer; 2001 Jan; 91(2):362-70. PubMed ID: 11180083
[TBL] [Abstract][Full Text] [Related]
6. Genetic mapping of allelic loss on chromosome 6q within heterogeneous prostate carcinoma.
Konishi N; Nakamura M; Kishi M; Ishida E; Shimada K; Matsuyoshi S; Nagai H; Emi M
Cancer Sci; 2003 Sep; 94(9):764-8. PubMed ID: 12967473
[TBL] [Abstract][Full Text] [Related]
7. Genetic pathways and new progression markers for prostate cancer suggested by microsatellite allelotyping.
von Knobloch R; Konrad L; Barth PJ; Brandt H; Wille S; Heidenreich A; Moll R; Hofmann R
Clin Cancer Res; 2004 Feb; 10(3):1064-73. PubMed ID: 14871986
[TBL] [Abstract][Full Text] [Related]
8. Chromosome 8p alterations in sporadic and BRCA2 999del5 linked breast cancer.
Sigbjörnsdottir BI; Ragnarsson G; Agnarsson BA; Huiping C; Barkardottir RB; Egilsson V; Ingvarsson S
J Med Genet; 2000 May; 37(5):342-7. PubMed ID: 10807692
[TBL] [Abstract][Full Text] [Related]
9. Identification of two distinct regions of allelic imbalance on chromosome 18Q in metastatic prostate cancer.
Padalecki SS; Troyer DA; Hansen MF; Saric T; Schneider BG; O'Connell P; Leach RJ
Int J Cancer; 2000 Mar; 85(5):654-8. PubMed ID: 10699945
[TBL] [Abstract][Full Text] [Related]
10. Clonal relationships between epidermotropic metastatic melanomas and their primary lesions: a loss of heterozygosity and X-chromosome inactivation-based analysis.
Bahrami S; Cheng L; Wang M; Jones TD; Malone JC; Billings SD
Mod Pathol; 2007 Aug; 20(8):821-7. PubMed ID: 17571079
[TBL] [Abstract][Full Text] [Related]
11. Loss of heterozygosity in clonal evolution with genetic progression and divergence in spindle cell carcinoma of the gallbladder.
Arakawa A; Fujii H; Matsumoto T; Hirai S; Suda K
Hum Pathol; 2004 Apr; 35(4):418-23. PubMed ID: 15116321
[TBL] [Abstract][Full Text] [Related]
12. Loss of heterozygosity at 7q31 is a frequent and early event in prostate cancer.
Latil A; Cussenot O; Fournier G; Baron JC; Lidereau R
Clin Cancer Res; 1995 Nov; 1(11):1385-9. PubMed ID: 9815935
[TBL] [Abstract][Full Text] [Related]
13. Allelic loss in human papillomavirus-positive and -negative vulvar squamous cell carcinomas.
Pinto AP; Lin MC; Mutter GL; Sun D; Villa LL; Crum CP
Am J Pathol; 1999 Apr; 154(4):1009-15. PubMed ID: 10233839
[TBL] [Abstract][Full Text] [Related]
14. Allelic loss in esophageal squamous cell carcinoma patients with and without family history of upper gastrointestinal tract cancer.
Hu N; Roth MJ; Emmert-Buck MR; Tang ZZ; Polymeropolous M; Wang QH; Goldstein AM; Han XY; Dawsey SM; Ding T; Giffen C; Taylor PR
Clin Cancer Res; 1999 Nov; 5(11):3476-82. PubMed ID: 10589761
[TBL] [Abstract][Full Text] [Related]
15. Allelotyping analysis at chromosome 13q of high-grade prostatic intraepithelial neoplasia and clinically insignificant and significant prostate cancers.
Lu W; Takahashi H; Furusato M; Maekawa S; Nakano M; Meng C; Kikuchi Y; Sudo A; Hano H
Prostate; 2006 Mar; 66(4):405-12. PubMed ID: 16302266
[TBL] [Abstract][Full Text] [Related]
16. Genetics of synchronous uterine and ovarian endometrioid carcinoma: combined analyses of loss of heterozygosity, PTEN mutation, and microsatellite instability.
Fujii H; Matsumoto T; Yoshida M; Furugen Y; Takagaki T; Iwabuchi K; Nakata Y; Takagi Y; Moriya T; Ohtsuji N; Ohtsuji M; Hirose S; Shirai T
Hum Pathol; 2002 Apr; 33(4):421-8. PubMed ID: 12055677
[TBL] [Abstract][Full Text] [Related]
17. A study of loss of heterozygosity at 70 loci in anaplastic astrocytoma and glioblastoma multiforme with implications for tumor evolution.
Wooten EC; Fults D; Duggirala R; Williams K; Kyritsis AP; Bondy ML; Levin VA; O'Connell P
Neuro Oncol; 1999 Jul; 1(3):169-76. PubMed ID: 11550311
[TBL] [Abstract][Full Text] [Related]
18. Loss of heterozygosity at 16q24.1-q24.2 is significantly associated with metastatic and aggressive behavior of prostate cancer.
Elo JP; Härkönen P; Kyllönen AP; Lukkarinen O; Poutanen M; Vihko R; Vihko P
Cancer Res; 1997 Aug; 57(16):3356-9. PubMed ID: 9269995
[TBL] [Abstract][Full Text] [Related]
19. Identification of genetic markers for prostatic cancer progression.
Alers JC; Rochat J; Krijtenburg PJ; Hop WC; Kranse R; Rosenberg C; Tanke HJ; Schröder FH; van Dekken H
Lab Invest; 2000 Jun; 80(6):931-42. PubMed ID: 10879743
[TBL] [Abstract][Full Text] [Related]
20. Loss of heterozygosity patterns provide fingerprints for genetic heterogeneity in multistep cancer progression of tobacco smoke-induced non-small cell lung cancer.
Pan H; Califano J; Ponte JF; Russo AL; Cheng KH; Thiagalingam A; Nemani P; Sidransky D; Thiagalingam S
Cancer Res; 2005 Mar; 65(5):1664-9. PubMed ID: 15753360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
